ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH.

Mona A Hegazy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.